Popular search terms:
Search Results
29 results found-
Here you will find the range of pharmaceutical products that we offer in the UK for immunodeficiency, haemophilia, and other rare and serious diseases.
https://www.cslbehring.co.uk/products/product-range -
CSL Behring is a specialty biotherapeutics company that is committed to treating people with rare and serious medical conditions.
https://www.cslbehring.co.uk/products -
CSL Behring is a global leader in the plasma protein biotherapies industry. We research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions.
https://www.cslbehring.co.uk/our-company -
CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions.
https://www.cslbehring.co.uk/research-and-development -
Product Name Idelvion 250 IU powder and solvent for solution for injection Active Ingredient Albutrepenonacog alfa (recombinant coagulation factor IX, albumin fusion protein) Composition One vial contains nominally 250 IU of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP), (INN = albutrepenonacog alfa).
https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/february-2024/idelvion-0224.pdf -
Product Name Berinert 500 IU powder and solvent for solution for injection Active Ingredient C1-esterase inhibitor, human Composition Berinert 500 contains 50 IU/ml C1-esterase inhibitor after reconstitution with 10 ml water for injections
https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2024-update/product-info---berinert-0424.pdf -
Product Name Fibrogammin 250 IU powder and solvent for solution for injection or infusion Active Ingredient Factor XIII Composition Fibrogammin contains approximately 62.5 IU/ml (250 IU/4 ml) of human plasma coagulation factor XIII when reconstituted with 4 ml water for injection
https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/april-2024-update/product-info---fibrogammin-0424.pdf -
CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide.
https://www.cslbehring.co.uk/terms-of-use -
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
https://www.cslbehring.co.uk/products/regulatory-compliance -
CSL Behring is committed to support Investigator-Initiated Studies (IIS) that advance medical and scientific knowledge of CSL Behring products and the diseases they are designed to treat.
https://www.cslbehring.co.uk/research-and-development/iis